Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia

References

• Park JW, Neve RM, Szollosi J, Benz CC. Unraveling the biologic and clinical complexities of HER2. Clin Breast Cancer 2008; 8: 392–401
   PubMed Web of Science ®Google Scholar
• Mukai H. Treatment strategy for HER2-positive breast cancer. Int J Clin Oncol 2010; 15: 335–340
   PubMed Web of Science ®Google Scholar
• Mannocci A, De Feo E, de Waure C, Specchia ML, Gualano MR, Barone C, Ricciardi W, La Torre G. Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: A systematic review of published studies. Tumori 2010; 96: 385–391
   Google Scholar
• Capala J, Bouchelouche K. Molecular imaging of HER2-positive breast cancer: A step toward an individualized ‘image and treat’ strategy. Curr Opin Oncol 2010; 22: 559–566
   PubMed Web of Science ®Google Scholar
• Smith TA. Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging. Br J Radiol 2010; 83: 638–644
   PubMed Web of Science ®Google Scholar
• Wuang SC, Neoh KG, Kang E, Pack DW, Leckband D. HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. Biomaterials 2009; 29: 2270–2279
   Web of Science ®Google Scholar
• Kikumori T, Kobayashi T, Sawaki M, Imai T. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res Treat 2009; 113: 435–441
   PubMed Web of Science ®Google Scholar
• Gilchrist RK, Medal R, Shorrey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann Surg 1957; 146: 596–606
   PubMed Web of Science ®Google Scholar
• Lacroix LM, Ho D, Sun S. Magnetic nanoparticles as both imaging probes and therapeutic agents. Curr Top Med Chem 2010; 10: 1184–1197
   PubMed Web of Science ®Google Scholar
• Santra S, Kaittanis C, Grimm J, Perez JM. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 2009; 5: 1862–1868
   PubMed Web of Science ®Google Scholar
• Alley SC, Okeley NM, Senter PD. Antibody-drug conjugates: Targeted drug delivery for cancer. Curr Opin Chem Biol 2010; 14: 529–537
   PubMed Web of Science ®Google Scholar
• Hu JCM, Zhang L. Therapeutic nanoparticles to combat cancer drug resistance. Current Drug Metabolism 2009; 10: 836–841
   PubMed Web of Science ®Google Scholar
• Mohs AM, Provenzale JM. Applications of nanotechnology to imaging and therapy of brain tumors. Neuroimaging Clin N Am 2010; 20: 283–292
   PubMed Web of Science ®Google Scholar
• Krishnan S, Diagaradjane P, Cho SH. Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy. Int J Hyperthermia 2010; 26: 775–789
   PubMed Web of Science ®Google Scholar
• Hilger I, Hergt R, Kaiser WA. Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 2005; 152: 33–39
   PubMedGoogle Scholar
• DeNardo S, DeNardo G, Natarajan A, Miers L, Foreman A, Gruettner C, Adamson G, Ivkov R. Thermal dosimetry predictive of efficacy of 111 in-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice. J Nucl Med 2007; 48: 437–444
   PubMed Web of Science ®Google Scholar
• Ivkov R, DeNardo S, Daum W, Foreman A, Goldstein R, Nemkov V, DeNardo G. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005; 11: 7093–7103
   PubMed Web of Science ®Google Scholar
• Lehmann J, Natarajan A, Denardo GL, Ivkov R, Foreman AR, Catapano C, Mirick G, Quang T, Gruettner C, Denardo SJ. Nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells. Cancer Biother Radiopharm 2008; 23: 265–271
   PubMed Web of Science ®Google Scholar
• Dennis CL, Jackson AJ, Borchers JA, Hoopes PJ, Strawbridge R, Foreman AR, van Lierop J, Grüttner C, Ivkov R. Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology 2009; 20: 395103 doi: 10.1088/0957-4484/20/39/395103
   PubMed Web of Science ®Google Scholar
• Grüttner C, Müller K, Teller J, Westphal F, Foreman A, Ivkov R. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J Magn Magn Mat 2007; 311: 181–186
   Web of Science ®Google Scholar
• Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ. NanoFerrite particle based radioimmunonanoparticles: Binding affinity and in vivo pharmacokinetics. Bioconjug Chem 2008; 19: 1211–1218
   PubMed Web of Science ®Google Scholar
• Kelm MA, Hammerstone JF, Schmitz HH. Identification and quantitation of flavanols and proanthocyanidins in foods: How good are the data?. Clin Dev Imm 2005; 12: 35–41
   PubMedGoogle Scholar
• Wang G, Dewilde AH, Zhang J, Pal A, Vashist M, Bello D, Marx KA, Braunhut SJ, Therrien JM. A living cell quartz crystal microbalance biosensor for continuous monitoring of cytotoxic responses of macrophages to single-walled carbon nanotubes. Part Fibre Toxicol 2011; 8: 4
   PubMed Web of Science ®Google Scholar
• Vorotnikova E, Rosenthal RA, Tries M, Doctrow SR, Braunhut SJ. Novel synthetic SOD/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation. Radiat Res 2010; 173: 748–759
   PubMed Web of Science ®Google Scholar
• Vorotnikova E, Ivkov R, Foreman A, Tries M, Braunhut SJ. The magnitude and time-dependence of the apoptotic response of normal and malignant cells subjected to ionizing radiation versus hyperthermia. Int J Radiat Biol 2006; 82: 549–559
   PubMed Web of Science ®Google Scholar
• Braunhut SJ, McIntosh D, Vorotnikova E, Zhou T, Marx KA. Detection of apoptosis and drug resistance of human breast cancer cells to taxane treatments using quartz crystal microbalance biosensor technology. Assay Drug Dev Technol 2005; 3: 77–88
   PubMed Web of Science ®Google Scholar
• Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Barni S. Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: A pooled analysis of two randomized trials. Anticancer Drugs 2011; 22: 128–135
   PubMed Web of Science ®Google Scholar
• Guarneri V, Barbieri E, Dieci MV, Piacentini F, Conte P. Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer. Cancer Treat Rev 2010; 36: 62–66
   Web of Science ®Google Scholar
• Saxena R, Dwivedi A, ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective. Med Res Rev 2010; DOI: 10.1002/med.20209
   Google Scholar
• Chu PY, Li TK, Ding ST, Lai IR, Shen TL. EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells. J Biol Chem 2010; 285: 29279–29285
   PubMed Web of Science ®Google Scholar
• Carver JR. Management of trastuzumab-related cardiac dysfunction. Prog Cardiovasc Dis 2010; 53: 130–139
   PubMed Web of Science ®Google Scholar
• Metzger Filho O, Saini KS, Azim Jr HA, Awada A. Prevention and management of major side effects of targeted agents in breast cancer. Crit Rev Oncol Hematol 2011; Sep 1. [Epub]
   Google Scholar
• Schlorf T, Meincke M, Kossel E, Glüer C, Jansen O, Mentlein R. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int J Mol Sci 2011; 12: 12–23
   Web of Science ®Google Scholar
• Tookman L, Roylance R. New drugs for breast cancer. Br Med Bull 2010; 96: 111–129
   PubMed Web of Science ®Google Scholar
• Roti-Roti JL. Cellular responses to hyperthermia (40–46°C): Cell killing and molecular events. Int J Hyperthermia 2008; 24: 3–15
   PubMed Web of Science ®Google Scholar
• Adraä W, d’Ambly CG, Hergt R, Hilger I, Kaiser WA. Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia. J Magn Magn Mat 1999; 194: 197–203
   Web of Science ®Google Scholar
• Kalambur VS, Longmire EK, Bischof JC. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 2007; 23: 12329–12336
   PubMed Web of Science ®Google Scholar
• Rabin Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?. Int J Hyperthermia 2002; 18: 194–202
   PubMed Web of Science ®Google Scholar
• Vauthier C, Tsapis N, Couvreur P. Nanoparticles: Heating tumors to death?. Nanomedicine (Lond) 2011; 6: 99–109
   PubMed Web of Science ®Google Scholar
• Yonezawa M, Otsuka T, Matsui N, Tsuji H, Kato KH, Moriyama A, Kato T. Hyperthermia induces apoptosis in malignant fibrous histiocytoma cells in vitro. Int J Cancer 1996; 66: 347–351
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Prosnitz L, Thrall D, Prescott D, Clegg S, Charles C, MacFall J, Rosner G, Samulski T, Gillette E, et al. Hyperthermic treatment of malignant diseases: Current status and a view toward the future. Sem Oncol 1997; 24: 616–625
   PubMed Web of Science ®Google Scholar
• Löfblom J, Feldwisch J, Tolmachev V, Carlsson J, Ståhl S, Frejd FY. Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett 2010; 584: 2670–2680
   PubMed Web of Science ®Google Scholar
• Ahlgren S, Orlova A, Wållberg H, Hansson M, Sandström M, Lewsley R, Wennborg A, Abrahmsén L, Tolmachev V, Feldwisch J. Targeting of HER2-expressing tumours using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold. J Nucl Med 2010; 51: 1131–1138
   PubMed Web of Science ®Google Scholar
• Barry SE. Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperthermia 2008; 24: 451–466
   PubMed Web of Science ®Google Scholar